Cost effectiveness study on the use of somatostatin for reduction of acute pancreatitis after ERCP;Estudio de coste-efectividad del empleo de somatostatina para la disminución de pancreatitis agudas post-CPRE

Gastroenterologia y Hepatologia

Volumn 24, Issue 6, 2001, Pages 292-296

  Borda, F ^a   Jimenez F J ^a   Vila, J ^a   Carral, D ^a   Zozaya, J M ^a   Pastor, G ^a   Aznarez, R ^a  

^a C/ Olite   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN;

ACUTE PANCREATITIS; ARTICLE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; SENSITIVITY AND SPECIFICITY;

EID: 0034933229     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5705(01)70177-x     Document Type: Article

References (28)

1. Severe and fatal complications after diagnostic and therapeutic ERCP: A prospective series of claims to insurance covering Public Hospitals
2. Twenty four serum amylase predicting pancreatic reaction after endoscopic sphincterotomy
3. Effect of somatostatin in the pancreatitis-like biochemical changes due to endoscopic pancreatography: Preliminary report
4. Effect of somatostatin on metabolic changes following ERCP
5. Effects of somatostatin on clinical, biochemical and morphological changes following ERCP
6. Effect of somatostatin on amylase level and pancreatitis rate following ERCP
7. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy
8. Endoscopic papilosphincterotomy: Prevention of pancreatic reaction by somatostatin
9. Can somatostatin prevent injection pancreatitis after CPRE?
10. The influence of somatostatin on pancreatic irritation after pancreatography: An experimental and clinical study
11. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: Results of a randomized study
12. Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial
13. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis
14. Primer on medical decision analysis: Part 5 - Working with Markov processes
15. An introduction to Markov modeling for economic evaluation
16. Complications with post-ERCP pancreatitis
17. Effects of somatostatin and a long acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat
18. ERCP and endoscopic sphincterotomy-induced pancreatitis
19. A comparison of non-ionic versus ionic contrast media: Results of a prospective multicenter study - Midwest Pancreatobiliary Study Group
20. Gabexate for prevention of pancreatic damage related to endoscopic retrograde pancreatography
21. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes
22. Diagnosis and management of acute pancreatitis
23. Metabolic management of severe acute pancreatitis
24. Review article: The relative effectiveness of somatostatin and octreotide therapy in pancreatic lesions
25. Meta-analysis of somatostatin, octreotide and gabelate mesilate in the therapy of acute pancreatitis
26. Does the somatostatin analog octreotide protect against ERCP induced pancreatitis?
27. Endoscopic sphincterotomy: A prospective series with emphasis on the increased risk associated with the sphincter of Oddi dysfunction and non-dilated bile ducts
28. Pancreatic sphincter hypertension increases the risk of ERCP-pancreatitis